Our team provides comprehensive support for biomarker exploratory research, target discovery studies for innovative drugs, and companion diagnostics services. Kanwhish Biotech has established multiple bioanalytical platforms suitable for biomarker research. These platforms include single-factor ELISA, multi-factor MSD and Luminex, flow cytometry, qPCR/ddPCR, LC-MS/MS, and others. We analyze biomarkers at multiple levels of different categories, including genetic, protein, cellular, and pathological tissue levels, as well as various sample types such as blood, bone marrow, tears, urine, and cerebrospinal fluid. Our goal is to provide our pharmaceutical clients with a one-stop solution for biomarker research.